InnoCan Pharma Corporation (CSE:INNO)
Canada
· Delayed Price · Currency is CAD 0.2250
0.00 (0.00%)
Jun 27, 2025, 3:20 PM EDT
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $7.80M USD in the quarter ending March 31, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $30.47M, up 61.49% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.
Revenue (ttm)
$30.47M
Revenue Growth
+61.49%
P/S Ratio
1.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
64.33M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sienna Senior Living | 896.45M |
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.58B |
| Extendicare | 1.47B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 179.08M |
| Trulieve Cannabis | 1.71B |
| Curaleaf Holdings | 1.89B |